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Abstract
The adaptation of growth in response to nutritional changes is essential for the proper development of all
organisms. Here we describe the identification of the Drosophila homolog of the target of rapamycin
(TOR), a candidate effector for nutritional sensing. Genetic and biochemical analyses indicate that
dTOR impinges on the insulin signaling pathway by autonomously affecting growth through modulating
the activity of dS6K. However, in contrast to other components in the insulin signaling pathway, partial
loss of dTOR function preferentially reduces growth of the endoreplicating tissues. These results are
consistent with dTOR residing on a parallel amino acid sensing pathway.
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The adaptation of growth in response to nutritional
changes is essential for the proper development of all
organisms. Here we describe the identification of the
Drosophila homolog of the target of rapamycin (TOR), a
candidate effector for nutritional sensing. Genetic and
biochemical analyses indicate that dTOR impinges on
the insulin signaling pathway by autonomously affecting
growth through modulating the activity of dS6K. How-
ever, in contrast to other components in the insulin sig-
naling pathway, partial loss of dTOR function preferen-
tially reduces growth of the endoreplicating tissues.
These results are consistent with dTOR residing on a
parallel amino acid sensing pathway.
Received July 17, 2000; revised version accepted September
21, 2000.
During the development of unicellular and multicellular
organisms, growth is dependent on the integration of di-
verse intracellular signals, which are triggered by pat-
terning and/or environmental cues (Oldham et al. 2000).
The availability of nutrients strongly influences growth
of single cells and multicellular organisms and in some
cases specifies alternative developmental programs. For
example, in yeast, nitrogen or carbon deprivation leads
to withdrawal from vegetative growth, arrest in G0, and
up-regulation of autophagy (Johnston et al. 1977; Oh-
sumi 1999). Likewise, in the nematode Caenorhabditis
elegans, limiting nutrients or overcrowding elicits an al-
ternative developmental program termed the dauer stage
(Riddle 1997). In this stage, the animal remains sexually
immature and stockpiles additional lipids for survival
during unfavorable growth periods (Kimura et al. 1997).
In more complex organisms such as insects and mam-
mals, an alternative developmental program is lacking.
Instead, nutrient limitation is managed by delaying de-
velopment and, in severe cases, reducing the final body
size of the organism. In the case of Drosophila, when
nutrients become limiting, available resources are mobi-
lized toward maintaining the growth of the mitotic tis-
sues, which during metamorphosis form smaller, yet
still fertile, flies (Robertson 1963).
In metazoans, one component of the complex physi-
ological response of energy homeostasis and growth con-
trol is the insulin and IGF signaling system (Efstratiadis
1998; Patti and Kahn 1998). Insulin and IGF activate two
main signaling pathways via the insulin receptor sub-
strates (IRS1–4): the Ras/MAPK pathway, which is in-
volved in proliferation, and the phosphatidyl-inositol
3-kinase (PI3K) signaling pathway, which is involved in
cell growth, survival, and metabolic homeostasis (White
1998; Rameh and Cantley 1999). PI3K mediates its ef-
fects on downstream signaling components through the
production of phosphatidylinositol 3,4,5-tris phosphate
(PIP3), which acts to recruit pleckstrin homology (PH)
domain–containing proteins like protein kinase B (PKB)
(Chan et al. 1999; Meier and Hemmings 1999). The ac-
tions of activated PI3K are antagonized by the 3-phos-
pho-inositol specific lipid phosphatase encoded by the
tumor suppressor gene PTEN (Maehama and Dixon
1999). An important protein implicated in the PI3K sig-
naling pathway is the target of rapamycin (TOR). TOR
has been reported to be regulated by PKB (Scott et al.
1998). Initially, TOR1 and TOR2 were identified in yeast
as mutations that conferred resistance to the antiprolif-
erative effects of rapamycin (Heitman et al. 1991). Rapa-
mycin is an antibiotic that inhibits both yeast TOR and
mammalian TOR (mTOR, also known as FRAP or
RAFT) function by forming an inhibitory complex with
the immunophilin, FK506 binding protein-12 (FKBP12),
that binds to a region adjacent to the kinase domain
termed the FKBP12-rapamycin binding domain (FRB;
Brown et al. 1994; Sabatini et al. 1994; Thomas and Hall
1997; Cutler et al. 1999). TOR is most related to the
ATM/DNA-PK family of checkpoint protein kinases and
is more distantly related to the PI3K family (Thomas and
Hall 1997; Cutler et al. 1999).
A key downstream target of mTOR function is protein
synthesis. In part, mTOR positively mediates protein
synthesis by modulating the activities of important
translational components, including the translation ini-
tiation factor 4E binding proteins (4E-BP1-3) and the ri-
bosomal protein S6 kinases (Chou and Blenis 1995;
Lawrence and Abraham 1997; Dennis et al. 1999). Under
conditions of reduced nutrients, such as amino acid limi-
tation, mTOR negatively regulates protein synthesis and
positively up-regulates autophagy (Dennis et al. 1999).
Thus, mTOR may serve as a nutritional checkpoint for
cell growth and ultimately, proliferation.
Little is known concerning the role of TOR during
metazoan development. Here we (see also, Zhang et al.
2000, this issue) describe the genetic and biochemical
characterization of the Drosophila homolog of TOR
(dTOR). We find that the strong dTOR mutants have
similar characteristics to upstream components in the
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dPI3K branch of the insulin pathway. Weak dTOR mu-
tants, however, display a unique phenotype. Unlike lar-
vae mutant for components of the insulin signaling path-
way, imaginal disks of larvae with reduced dTOR func-
tion grow to their normal size at the apparent expense of
the endoreplicating tissue.
Results and Discussion
We recently established a tissue-specific genetic screen
for recessive mutations affecting cell growth and prolif-
eration in the Drosophila compound eye. In this screen,
genetically mosaic flies are generated in which the eye
and head capsule are homozygous for a randomly in-
duced mutation, while the rest of the body and the germ
line are heterozygous and, thus, phenotypically wild
type. Remarkably, mosaic flies containing a mutation in
a growth-promoting gene have eye and head structures
that are strongly reduced in size relative to their wild-
type sized heterozygous bodies and are termed pinhead
flies (Fig. 1A). Two EMS-induced pinhead mutations
(2L1 and 2L19; Fig. 1B,C) mapped to chromosomal posi-
tion 34A, where the Drosophila homolog of TOR (dTOR)
is located (Adams et al. 2000). These mutations fail to
complement two lethal P-element insertions, EP(2)2353
and l(2)k17004 (To¨rok et al. 1993; Rørth et al. 1998; Spra-
dling et al. 1999), located 262 and 211 bp, respectively,
upstream of the putative translation start site of dTOR
(Fig. 1E). The dTOR genomic region spans ∼10 kb and is
composed of seven exons (7.4 kb cDNA) encoding a
2480-amino acid protein with a predicted Mw of 282 kD
(Fig. 1E). The dTOR protein exhibits 35%, 38%, 35%,
and 41% overall amino acid identity to yeast TOR1,
TOR2, C. elegans TOR, and Arabidopsis thaliana TOR,
respectively. The overall identity with mTOR is signifi-
cantly higher (56%) and is especially conserved in the
kinase and FRB domains (74% and 77%). Sequence
analysis of DNA from flies heterozygous for the EMS-
induced dTOR mutations revealed two nucleotide sub-
stitutions. The lesion of dTOR2L1 results in a change of
a proline to a leucine at amino acid position 2303
(P2303L; Fig. 1E). The location of this mutation within a
highly conserved region of the kinase domain implies
that the kinase activity of dTOR is critical for its func-
tion, as has been shown for the yeast TORs (Zheng et al.
1995). In contrast, the lesion in dTOR2L19 is an arginine
changed to a nonsense mutation at amino acid residue
248 (R248Stop), giving rise to a stop codon. This muta-
tion would be predicted to result in a short, truncated
protein and should thus be a complete loss-of-function
mutation.
The phenotypes associated with the complete loss of
dTOR function are remarkably similar to phenotypes as-
sociated with mutations in the insulin receptor (Inr)
pathway. First, strong dTOR mutants arrest develop-
ment at a similar stage as do strong mutants in the Inr
pathway or amino acid–starved larvae with little detect-
able imaginal tissue (see below). Second, dTOR mutant
clones have a significant proliferative disadvantage simi-
lar to Inr pathway mutant clones (data not shown).
Clones of dTOR null mutant cells, although severely
affected, are not cell lethal. Similarly, in most mamma-
lian cell types, rapamycin decreases but does not abolish
cell growth, except for IL2-mediated T-cell proliferation
(Chou and Blenis 1995). Third, the strict autonomous
control of cell growth without disturbing the specifica-
tion and differentiation is also seen with the dTOR mu-
tants. Indeed, loss of dTOR function in clones of homo-
zygous mutants cells in the adult eye showed that only
the mutant cells, as exemplified by the dark, circular
rhabdomeres, are severely reduced in size (Fig. 2C).
Analysis of imaginal wing disk cells at the end of the
third larval instar by fluorescence-activated cell sorting
(FACS), confirmed that cells from the weak heteroallelic
combination, dTOR2L1/dTORl(2)k17004, are smaller
than those of wild type (Fig. 2B). The effect on cell size is
more pronounced in G1 than G2 (data not shown), con-
sistent with mTOR function having a predominate role
on cell growth during G1 (Terada et al. 1993; Barbet et al.
1996). Despite this observation, there is no apparent dif-
ference between the distribution of dTOR mutant and
wild-type cells within each phase of the cell cycle (Fig.
Figure 1. Identification of dTOR. Tissue-specific induction of
dTOR2L1 and dTOR2L19 mutant clones using the ey-Flp tech-
nique (Newsome et al. 2000) produced flies with reduced head
size relative to their body. (A) Dorsal view of y w ey-Flp; P(w+)
l(2)2L-3.1 FRT40/CyO y+ (right) and y w ey-Flp; dTOR2L1
FRT40/P(w+) l(2)2L-3.1 FRT40 (left). Flies of the following ge-
notype were examined by SEM: (B) y w ey-Flp; dTOR2L19
FRT40/P(w+) l(2)2L-3.1 FRT40; (C) y w ey-Flp; dTOR2L1 FRT40/
P(w+) l(2)2L-3.1 FRT40; (D) wild-type eye. Bar, 100 µm. (E) Ge-
nomic structure and mutants of dTOR. The grey region consists
of the coding region, and the gaps indicate introns. The percent-
age amino acid identity of each domain to human TOR is shown
in parentheses.
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2A). Although the similarities of the loss-of-function
mutant phenotypes of dTOR and other components of
the Inr pathway are consistent with a model in which
dTOR acts downstream of dPI3K, the analysis of partial
loss-of-function dTOR mutants and the biochemical
analysis of dS6K activity (see below) indicates a more
complex relationship between dTOR and the Inr path-
way.
We examined genetic interactions between dTOR mu-
tants and other mutations in the insulin pathway.
dPTEN encodes a negative effector of insulin signaling
(Goberdhan et al. 1999; Huang et al. 1999), and eyes and
heads lacking dPTEN function are significantly larger
than wild-type heads (Fig. 2D,E; Gao et al. 2000). Re-
moval of dTOR function strongly reduced the size of
dPTEN mutant heads (Fig. 2F), suggesting that dTOR is
required for the increased growth generated by the loss of
dPTEN function.
In vertebrates, S6K activity is blocked by rapamycin,
an inhibitor of TOR. Therefore, we analyzed dS6K activ-
ity in immunoprecipitates of extracts from larvae mu-
tant for dTOR, dS6K, chico, and larvae treated with rapa-
mycin or deprived of amino acids. A severe reduction in
the phosphorylation of ribosomal protein S6 was ob-
served in extracts from strong dTOR2L1/dTOR2L19 mu-
tant larvae (Fig. 3, cf. lanes 1 and 3). This was not caused
by a reduction in dS6K protein as shown by Western
blotting of these extracts (Fig. 3). In addition, we consis-
tently noted that the dS6K protein was up-regulated in
the dTOR mutant larvae and amino acid–starved larvae.
In all cases, Western blot analysis showed equivalent
amounts of initiation factor 4E (eIF-4E; Fig. 3). dS6K ac-
tivity was not detected in dS6Kl-1 null mutants and was
severely reduced when wild-type larvae were starved for
amino acids or treated with rapamycin (Fig. 3, lanes
2,4,6). Higher doses of rapamycin blocked development
during early larval stages, leading to lethality (data not
shown). Analysis of the weak dTOR2L1/dTORl(2)k17004
or dTOR2L1/dTOREP(2)2353 heteroallelic combinations
also revealed a reduction in dS6K activity in the third
larval instar and an up-regulation of the protein as com-
pared with wild-type flies (Fig. 3, cf. lane 7 with lanes 10
and 11). The surprising fact that dTOR mutants and
amino acid starvation result in an up-regulation of dS6K
levels suggests that dTOR and amino acids may nega-
tively control the protein levels of dS6K. Unexpectedly,
dS6K activity as well as protein levels were unaffected in
chico mutants (Fig. 3, lane 9). It may be that Inr does not
signal to dS6K or that dS6K resides on a parallel pathway
that bifurcates upstream of Chico. In support of the lat-
ter possibility, Inr has been shown to genetically interact
with dPI3K independently of Chico (Boehni et al. 1999),
presumably through docking sites for the p60 adaptor of
dPI3K in the Inr C-terminal tail. This result suggests that
there is a dS6K independent pathway for growth control
and that the reduced Inr-mediated dPI3K signaling in a
chico mutant is sufficient for dS6K activation.
The biochemical differences between the ability of
Chico and dTOR to activate dS6K argue for a more com-
plex relationship between the Inr pathway and dTOR.
Given the low number of pharate adults, we compared
the weight of dTOR, dS6Kl-1, and chico mutants at an
early pupal stage (Fig. 4A). The weight of the dTOR mu-
tant pupae is more similar to dS6K than to chico mutant
pupae (Fig. 4B). Thus, in the absence of dS6K function or
the presence of reduced dTOR levels, cellular growth
rates are diminished but larvae pupariate at a larger size
Figure 2. dTOR acts autonomously in the control of cell
growth in the eye. (A,B) FACS analysis of dTOR2L1/
dTORl(2)k17004 mutant wing disks showing forward scatter (FSC)
and cell cycle distribution. (C) Section through an eye contain-
ing a mitotic clone of dTORl(2)k17004. The area of the mutant
clone is demarcated by the absence of red pigment. At the
boundaries of the clone, ommatidia consist of mixed wild-type
heterozygous and homozygous mutant cells. (D–F) Flies were
examined by SEM. (D) y w control. (E). Loss of dPTEN function
in the eye and head capsule results in a fly with a big head. (F)
The large head caused by loss of dPTEN function in the eye can
be suppressed by homozygosity for dTOREP(2)2353. Bar, 200 µm.
Figure 3. dTOR mutations and amino acid starvation affect
the level and activity of dS6K. In vitro kinase assay to assess the
levels of dS6K activity (top) and Western blot of the protein
levels of dS6K and Drosophila eIF-4E (bottom).
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as a result of a longer developmental delay. Importantly,
dS6K mutant flies have cells that are smaller but of the
normal number (Montagne et al. 1999). However, in
chico mutants, pupariation is initiated at a much smaller
size. The result is that chico mutants emerge after only
a 2-d delay and are smaller than dTOR and dS6K mu-
tants because of fewer and smaller cells (Boehni et al.
1999; Montagne et al. 1999; data not shown). Therefore,
while insulin signaling controls cell size and cell num-
ber, dS6K primarily controls cell size. It will be of inter-
est to know whether dTOR is also limited to controlling
only cell size.
Larvae are composed of mitotic cells, largely repre-
sented by the imaginal disks, and of endoreplicating tis-
sues, which form larval structures like the gut, fat body,
and salivary glands. An increase in DNA ploidy of larval
cells is required for the ∼200-fold increase in mass ob-
tained by the larvae during the 5-d period between the
completion of embryogenesis and the beginning of pupa-
tion (Church and Robertson 1966). During starvation,
larvae sacrifice their endoreplicating tissue to maintain
the growth and proliferation of the mitotic cells that are
required to form the reproductive adult (Britton and
Edgar 1998). Furthermore, dS6K activity is reduced in
starved larvae and dTOR mutants (Fig. 3). These obser-
vations prompted us to analyze the mitotic and endorep-
licating tissues of dTOR, dS6K, and chico mutant larvae
just before pupariation. Strong dTOR and dPI3K mu-
tants, as well as amino acid–starved larvae, are incapable
of growth and have barely detectable imaginal and en-
doreplicative tissues (Fig. 4C; Weinkove et al. 1999; data
not shown). Surprisingly, the wing disks of the weak
dTOR heteroallelic combination were of approximately
equivalent size to that of wild-type larvae, whereas those
of dS6Kl-1 mutants were reduced (Fig. 4D). However, the
amount of endoreplicating tissue in the dTOR mutant as
compared to wild-type larvae was severely decreased.
This is clearly demonstrated by comparing the salivary
glands of dTOR mutant and wild-type larvae (Fig. 4D). In
contrast, the size of endoreplicating tissue and imaginal
disks in dS6K null mutants as well as chico null mutants
was reduced in size to approximately the same extent
(Fig. 4D). Staining of the salivary glands with DAPI and
phalloidin revealed that the size of the nuclei and, thus,
the degree of endoreplication was severely reduced in
dS6K, chico, and dTOR mutants (Fig. 4E). The difference
in size between dTOR and dS6K mutant salivary glands
is largely caused by a very pronounced reduction in cy-
toplasmic volume in dTOR mutants. The nuclear to cy-
toplasmic ratio was higher in dTOR salivary glands than
in y w, dS6K, or chico mutant salivary glands (4.5, 2.25,
and 2.1 times, respectively). Thus, it appears that partial
loss of dTOR function permits the growth of imaginal
tissue to wild-type size, while endoreplicating tissue is
disproportionally reduced, a phenotype distinct from
dS6K mutants. Consistent with this finding, we were
unable to rescue the lethality of the different dTOR mu-
tants by constitutive expression of a S6K1 variant, D3E-
E389, which exhibits high basal activity in the absence of
mitogens (Dennis et al. 1996) under the control of the
-tubulin promoter, which rescues all aspects of the
dS6Kl-1 null phenotype (Montagne et al. 1999; data not
shown). Therefore, dS6K-independent processes must
contribute to the weak dTOR phenotype.
The effect of rapamycin and amino acids on transla-
tion is mediated through the S6Ks and the 4E-BPs (Den-
nis et al. 1999). Unlike the other elements in the PI3K
signaling pathway, absence of amino acids blocks both
S6K activation and 4E-BP phosphorylation (Blommaart
et al. 1995; Hara et al. 1998). Indeed, a mutant of S6K1,
lacking a portion of both its amino and carboxyl termini,
is resistant to rapamycin but still sensitive to the fungal
metabolite wortmannin, an inhibitor of PI3K. This sug-
gests that the PI3K-dependent signal to S6K activation
does not involve TOR. This same mutant is also unaf-
fected by amino acid withdrawal, consistent with the
Figure 4. dTOR larval and pupal mutant phenotypes. (A) Pupal
sizes of the various mutant combinations. Pupae were collected
just after puparium formation. (B) Pupal weights of the various
mutant combinations. Gray bars are female, black bars are
male. (C) Heteroallelic combinations of dTOR mutant larvae
compared with mutants of other components in the Inr path-
way. All larvae were taken from a staged collection at day 5.
dTOR(w) is dTOR2L1/dTORl(2)k17004, dTOR(s) is dTOR2L1/
dTOR2L19, dPI3K is a null mutation (Weinkove et al. 1999), and
dS6K is dS6Kl-1. (D) The size of mutant disks and salivary glands
of hypomorphic dTOR mutants are distinct from dS6K and
chico. (E) DAPI and phalloidin staining of salivary glands from
y w, dS6Kl-1, chico, and dTOR2L1/dTORl(2)k17004 mutant larvae.
All disks and salivary glands were taken from larvae that had
everted their spiracles just before pupariation.
Oldham et al.
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role of mTOR as an amino acid checkpoint in S6K acti-
vation (Hara et al. 1998; Dennis et al. 1999). Although
there is some controversy concerning the ability of mi-
togens to activate mTOR, we find, as have others (Gin-
gras et al. 1999; cited in Hara et al. 1998), that the in vitro
activity of mTOR from cultured cells toward either it-
self, S6K1, or 4E-BP1 is unaffected by mitogens (P.B.
Dennis and G. Thomas, unpubl.). Thus, mTOR may act
as a permissive signal that primes 4E-BP phosphoryla-
tion and S6K activation by the PI3K signaling pathway if
amino acids, and possibly other nutrients, are at suffi-
cient levels (Hara et al. 1998; Gingras et al. 1999). Like-
wise, in Drosophila larvae, amino acids are necessary,
but not sufficient, for imaginal disk and endoreplicating
tissue proliferation (Britton and Edgar 1998), compatible
with dTOR acting in a parallel pathway involved in
amino acid sensing (Fig. 5). The fact that chico mutant
larvae have normal levels of dS6K activity and that the
dTOR larval phenotypes with respect to the imaginal
disks and endoreplicating tissues are so distinct com-
pared with other mutants in the Inr pathway, supports
the possibility that dTOR is not responsive to insulin
signaling.
It is well established in yeast that TOR is an important
mediator of nutrient limitation, and it has been proposed
that TOR acts as an amino acid effector to coordinate the
response of yeast to different nutritional conditions (Bar-
bet et al. 1996). Indeed, the similarities between dTOR
mutant larvae and larvae deprived of amino acids are
striking. Therefore, it is likely that dTOR also functions
as an amino acid sensor in multicellular organisms. The
fact that yeast and Arabidopsis do not have an insulin
system suggests that TOR may be an ancestral and wide-
spread nutritional sensor. To provide additional levels of
control, it may have been integrated into the insulin sys-
tem later to respond to different modes of nutrient dep-
rivation with different developmental responses.
Materials and methods
Molecular characterization of dTOR
We used the ey-FLP method (Newsome et al. 2000) for a tissue-specific F1
screen for recessive mutations affecting cell growth and proliferation.
Two EMS-induced alleles (dTOR2L1 and dTOR2L19) that produce flies
with small heads relative to their heterozygous, phenotypically wild-type
sized bodies were identified and failed to complement two P-element
insertions in the 5 region of dTOR. The genomic structure was predicted
by GENSCAN and GADFLY (GENSCAN, http://genes.mit.edu/
GENSCAN.html; BDGP, http://www.fruitfly.org).
Clonal and larval analysis
Clonal analysis was done as described (Boehni et al. 1999). The following
genotypes were used to compare mosaic clones of dPTEN versus dPTEN–
dTOR mutants: y w ey-Flp; P(w+) l(2)2L-3.1 FRT40/FRT40 dPTEN117 and
y w ey-Flp; P(w+) l(2)2L-3.1 FRT40/FRT40 dPTEN117, dTOREP(2)2353. For
imaginal disk/salivary gland and FACS analysis, late third instar larvae
just before pupariation were examined as previously described (Montagne
et al. 1999). Imaginal disks and salivary glands were dissected and fixed
in paraformaldehyde as described (Montagne et al. 1999). DAPI and phal-
loidin staining were performed following standard procedure and ana-
lyzed by confocal imaging. The nuclear and cytoplasmic volumes were
derived from nuclear radial and internuclei measurements, respectively,
from 10 independent salivary glands. These measurements were con-
verted to volumes using the formula V = 4/3r3. The cytoplasmic vol-
ume was determined by subtracting the nuclear volume from the total
cell volume.
S6K assay
Amino acid–starved larvae were obtained as described (Britton and Edgar
1998). For the rapamycin (Calbiochem) feeding, 24 h after egg laying, 100
µL of a 40 µM rapamycin solution was added once a day for up to 6 d. Five
days AED, rapamycin-fed larvae were developmentally delayed at the
second instar. Larvae were extensively washed, frozen in liquid nitrogen,
and squashed in extraction buffer (Stewart et al. 1996). Cell debris was
removed by centrifugation and for each dS6K activity assay, 40 µg of total
protein extract was immunoprecipitated using 10 µL of a monoclonal
antibody generated by NOVARTIS, using a fusion protein between malt-
ose binding protein (New England Biolabs) and the carboxy-terminal
amino acids 435–490 of dS6K. After incubation with 20 µL of protein-G
Sepharose (Amersham Pharmacia), immuno complexes were sedi-
mented, extensively washed, and assayed for [32P] Pi incorporation as
previously described (Stewart et al. 1996). Western blotting was per-
formed with polyclonal antibodies directed against the amino terminus
of dS6K (Stewart et al. 1996) or the Drosophila eIF4E (provided by J.M.
Sierra, Centro de Biologia Molecular Severo Ochoa).
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Figure 5. Model showing the possible relationship of dTOR
with the insulin pathway. The unexpected finding that hypo-
morphic mutations of dTOR, but not null mutations of chico,
strongly inhibit dS6K activity may be explained by a two-
threshold model. The threshold for dS6K inactivation by dTOR
is low, whereas that for dS6K inactivation by the Inr pathway is
high. Thus, a low level of PI3K signaling from Inr may be suf-
ficient for dS6K activation in the absence of Chico. Dashed
arrow indicates indirect or unclear interaction. Solid arrow in-
dicates direct interaction.
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